Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 1 year ago

Anticoagulation

MI/ACS
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 1 year ago

Anticoagulation

Intervention
AHA 24: The OPTION Trial
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more

Anticoagulation

Electrophysiology & Arrhythmia
Coronary Reactivity Testing for Non‑Obstructive CAD: Case Overview
Author(s): Robert Jay Widmer Added: 2 months ago
Welcome to the introductory segment of Dr Robert Jay Widmer's 'Cath Lab Guide to Coronary Reactivity Testing in Non‑Obstructive CAD'.Dr Widmer (The McKinney Heart Hospital, US) presents the case of a 25-year-old female endurance runner experiencing exertional, band-like chest pain. Her coronary CTA appears normal, while PET imaging reveals mildly reduced flow confined to the circumflex territory… View more

Intervention
Cath Lab Guide to Coronary Reactivity Testing in Non‑Obstructive CAD
Author(s): Robert Jay Widmer Added: 2 months ago
This expert level cath lab case features Dr Jay Robert Widmer (The McKinney Heart Hospital, US) demonstrating a complete invasive coronary reactivity testing protocol in a 25 year old woman with persistent chest pain, normal coronary CTA and non-obstructive findings.Dr Widmer walks through step-by-step assessment of coronary microvascular function using thermodilution derived CFR and IMR,… View more

Intervention
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 6 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
ACC.26 Late-breaker Discussion: The CHAMPION-AF Trial
Author(s): Saibal Kar , Harriette Van Spall Added: 1 month ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more

Intervention

Anticoagulation
The Role of Non-invasive Tests in Pulmonary Embolism
Author(s): Ana Torremocha , Daniel Tébar , Alfonso Jurado-Román Added: 7 months ago

Imaging & Diagnostics

Intervention
The XLIMIT Trial: XLIMUS® DES Shows Non-Inferiority to Synergy™ DES
Author(s): Luca Testa Added: 1 year ago
Dr Luca Testa (IRCCS Policlinico San Donato, IT) discusses the results of the XLIMIT Trial at the EuroPCR 2024 congress in Paris, France.In this video interview, Dr Testa explains the technology behind the XLIMUS® drug-eluting stent (Cardionovum®) and its benefits. He also reviews the XLIMIT Trial, detailing the study design, selection criteria and clinical outcomes.Specifically, the 6 to 9… View more

Intervention
Outcomes of CTO PCI in a Non-surgical Centre
Author(s): Thomas R Gilpin , Annette Maznyczka , Brijesh Anantharam , et al Added: 2 years ago

Intervention

Prevention & Chronic Conditions